Environmental, Social, and Governance

Standards We Live By

Our environmental, social, and governance (ESG) standards guide how we operate responsibly and create long-term value for our colleagues, clients, patients, and communities. Following Caidya’s strategic combination with Simbec-Orion, we are bringing together our respective ESG practices and commitments to further develop our sustainability goals, strengthen accountability, and expand how we measure and manage our environmental and social impact.

Caidya's Environmental Policy

We believe we don’t have to choose between clinical development and protecting the future. So, we minimize our environmental impact through thoughtful, evolving ESG practices like: 

Reducing Our Carbon Footprint

We measure our Scope 1, Scope 2, and Scope 3 greenhouse gas emissions (based on GHG Protocol) annually and are taking steps to reduce our environmental impact. Our climate commitments include establishing formal GHG reduction targets and working toward carbon neutrality by 2050.

Minimizing Waste

We work to reduce waste and environmental impact through responsible procurement, digital-first workflows, recycling, reuse, and more efficient use of resources. Where appropriate, environmental considerations are incorporated into purchasing decisions, including lifecycle resource use, waste, emissions, sustainable sourcing, durability, reuse, and end-of-life recyclability.

Partnering for Sustainability

Our risk-based approach to supplier governance includes incorporating ESG considerations into service provider selection and qualification where appropriate, while encouraging our partners to maintain responsible environmental, ethical, and employment practices.

Accountability & Compliance

We meet global environmental standards and continuously evolve our approach to sustainable, responsible operations. This includes annual greenhouse gas emissions measurement, climate-related disclosure, defined reduction targets, and ongoing evaluation of opportunities to reduce our environmental footprint.

Health Sector CARES Pledge

We are a signatory to the Health Sector CARES (Climate Action, Resilience, and Equity Solutions) Pledge, reinforcing our commitment to measurable climate action and greater resilience. Through the pledge, participating organizations commit to reducing Scope 1 and Scope 2 emissions by at least 50% by 2030 and achieving carbon neutrality by 2050, while publicly accounting for progress each year. 

The pledge also includes commitments to share strategies for reducing emissions, develop a climate resilience plan, designate an executive-level lead for emissions reduction, and maintain an inventory of Scope 3 emissions. 

Measuring and Reporting Our Impact

We measure our Scope 1, Scope 2, and Scope 3 greenhouse gas emissions annually to better understand our environmental impact and identify opportunities for reduction. We also participate in the annual CDP Climate Change Disclosure, supporting greater transparency around climate-related risks, opportunities, emissions, and environmental performance. 

Smarter, Lower-Impact Trial Delivery

Sustainability is part of how we operate. We lower our environmental impact while maintaining speed, quality, and flexibility across clinical development phases with initiatives like: 

Flexible Work Model

Remote-first operations and fewer physical offices reduce travel, energy use, and overhead while enabling global teams to collaborate efficiently.

Digital-First Infrastructure

Cloud-based systems and electronic signatures minimize paper, eliminate physical servers, and streamline secure, compliant workflows.

Sustainable Trial Execution

Electronic data capture (EDC), hybrid trial models, and remote monitoring reduce manual processes, paper use, and on-site travel.

Responsible Partnerships

We prioritize sustainable vendors and support local community initiatives, encouraging teams to contribute meaningfully where they live and work. 

Frequently Asked Questions
on ESG and Clinical Trials

How does ESG impact clinical trial delivery?

ESG-focused practices improve efficiency, reduce waste, and enable more flexible trial models—helping sponsors maintain quality while optimizing timelines and resources.

Do ESG practices affect study timelines or costs?

In many cases, they enhance efficiency. Digital tools, remote models, and streamlined operations can reduce delays, lower costs, and improve overall trial performance.

Explore our case studies to see the impact ESG can have on clinical trials.

View Case Studies 

Can ESG practices support patient-centric trials?

Yes. Approaches like hybrid and decentralized models reduce patient burden, improve access, and support more inclusive participation.

How does ESG support long-term innovation?

By integrating sustainability and accountability into operations, we create a more resilient foundation for innovation and future clinical development.